PATH Stock Slips As RBC Slashes UiPath Price Target

UiPath Inc. stocks have been trading down by -3.89 percent amid bearish sentiment over automation software demand and competition.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading PATH

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

RBC Capital cut UiPath’s PATH price target from $14 to $12 while keeping a Sector Perform rating.
The firm wants to see several quarters of consistent execution before turning more positive on PATH.
Analysts cited weak job posting trends and questions around non-seed pricing as key headwinds for UiPath.
Street consensus on PATH still sits at “hold,” with a mean price target of $13.67, implying only modest upside.

Live Update At 16:02:08 EDT: On Tuesday, June 09, 2026 UiPath Inc. stock [NYSE: PATH] is trending down by -3.89%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

UiPath, trading under the PATH ticker, is sitting in that tricky zone where the business is improving, but the market is not fully convinced. Recent daily closes show PATH fading from the mid-$12s to around $10.75, a clear pullback from the late‑May pop to $13.10. That tells traders the early bounce lost steam and sellers are leaning on the stock.

Intraday action reinforces the story. PATH opened near $11.00 and spent the regular session grinding down toward the low $10s with tight 5‑minute candles and small ranges. That type of slow bleed, without big volume spikes, often reflects quiet distribution rather than panic.

Fundamentally, UiPath is not a broken company. PATH generated about $1.61B in revenue with a strong 83% gross margin, and Q1 2026 revenue of $418.38M came with positive net income of $22.53M and EBITDA of $52.79M. Free cash flow was a healthy $129.24M, and PATH’s balance sheet is clean with very low debt and a current ratio of 2.3, signaling plenty of liquidity.

More Breaking News

Valuation is no longer nosebleed. A P/E of 16.48 and price‑to‑sales near 3.2 put PATH closer to a “reasonable growth” bucket rather than the hyper‑speculative AI names.

Why Traders Are Watching PATH After The RBC Cut

The catalyst on the tape is clear: RBC Capital just took UiPath’s PATH price target down from $14 to $12 while reaffirming a Sector Perform rating. That is not a disaster call, but it is a shot across the bow for traders hoping PATH would ride the AI automation hype back to prior highs. When a major bank cuts targets ahead of earnings, short‑term sentiment often shifts from “buy the dip” to “prove it.”

RBC laid out exactly what worries them. First, UiPath needs several straight quarters of clean execution. For traders, that means PATH is now in a “show me” phase. Choppy results or messy guidance will be punished. Smooth numbers and steady growth, quarter after quarter, are what can slowly squeeze shorts and drag the stock higher again.

Second, the note flags non‑seed pricing progress and clearer AI‑driven benefits. Translation: PATH is selling automation and AI, but big clients still want to see direct payoffs before paying up on licenses beyond the initial seats. Until UiPath proves those economics clearly, many funds will treat PATH as a range‑trading name, not a momentum leader.

RBC also called out negative job posting trends around UiPath. That matters. When fewer enterprises are hiring around a platform, it often signals slower expansion and weaker demand later on. For short‑term trading, that backdrop lines up with the chart: PATH losing altitude from $13.10 into the low $11s and now the mid‑$10s, as the Street re‑prices growth expectations down toward that new $12 target.

At the same time, the broader sell‑side consensus on PATH remains a hold with a mean target of $13.67. So this is not a mass downgrade cycle; it is more like pressure on the ceiling. Traders now know the lane: analysts see UiPath worth roughly $12–$14 unless execution meaningfully improves.

Conclusion

For active traders, PATH is shaping up as a classic battleground stock around the $10–$12 zone. On one side, UiPath’s fundamentals are not falling apart: solid gross margins, positive earnings, and strong free cash flow support the long‑term automation story. On the other, RBC’s cut to a $12 price target and concerns over execution, pricing leverage, and job‑posting softness cap near‑term enthusiasm.

That mix often turns into a range‑bound chart where sentiment, not story, drives the next move. If PATH posts a clean Q1 and guides confidently, traders may lean on the still‑reasonable valuation and try to push it back toward the $13.67 Street average. If UiPath stumbles or delivers fuzzy commentary on AI monetization, the market will remember RBC’s note and likely press the downside.

This is where discipline separates pros from gamblers. PATH offers real opportunity, but it also carries headline risk and earnings‑gap danger. Size and timing matter. As Tim Sykes likes to remind his trading community, “Hype fades, but risk never does. Study the pattern, respect the downside, and never be afraid to sit in cash when a stock hasn’t proven itself yet.” As Tim Bohen, lead trainer with StocksToTrade says, “The best way to learn is by tracking trades, wins, losses, and lessons learned. Every trade has something to teach.” For traders following UiPath and PATH, that mindset fits this chart perfectly.

This article is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!